Cases 11 - 20 of 65
Bayer Pharma AG et al v. Apotex Inc. et al
as 1:2022cv01596
Plaintiff:
Bayer Pharma AG, Bayer AG and Janssen Pharmaceuticals, Inc.
Defendant:
Apotex Inc. and Apotex Corp.
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
Gilead Sciences, Inc. v. Apotex Inc. et al
as 1:2022cv01400
Plaintiff:
Gilead Sciences, Inc.
Defendant:
Apotex Inc. and Apotex Corp.
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
Gilead Sciences, Inc. et al v. Apotex Inc. et al
as 1:2022cv01399
Plaintiff:
Gilead Sciences, Inc., Gilead Sciences Ireland UC, Janssen Products, L.P. and others
Defendant:
Apotex Inc. and Apotex Corp.
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
Zogenix, Inc. et al v. Apotex Inc. et al
as 1:2022cv01232
Plaintiff:
Zogenix, Inc. and Zogenix International Ltd.
Defendant:
Apotex Inc., Apotex Corp. and Lupin Limited
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
Galderma Laboratories, L.P. et al v. Apotex Inc. et al
as 1:2022cv00724
Plaintiff:
Galderma Laboratories, L.P. and TCD Royalty Sub LP
Defendant:
Apotex Inc. and Apotex Corp.
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
In Re: Xarelto (Rivaroxaban) ('310) Patent Litigation
as 1:2021md03017
In Re:
Xarelto (Rivaroxaban) ('310) Patent Litigation
Not Classified By Court:
Clerk of MDL Panel, Lupin Limited, Lupin Pharmaceuticals, Inc. and others
Counter Defendant:
Bayer Pharma AG, Bayer AG and Janssen Pharmaceuticals, Inc.
Defendant:
ScieGen Pharmaceuticals, Inc.
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
Zogenix, Inc. et al v. Apotex Inc. et al
as 1:2021cv01533
Plaintiff:
Zogenix, Inc. and Zogenix International Ltd.
Counter Claimant:
Apotex Inc.
Defendant:
Apotex Corp.
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
Bayer Healthcare LLC et al v. Apotex Inc. et al
as 1:2021cv01429
Plaintiff:
Bayer Healthcare LLC and Meda Pharmaceuticals Inc.
Defendant:
Apotex Inc. and Apotex Corp.
Cause Of Action: 35 U.S.C. § 1
Pfizer Inc. et al v. Apotex Inc. et al
as 1:2021cv01402
Plaintiff:
Pfizer Inc., Pfizer Products Inc., PF Prism C.V. and others
Defendant:
Apotex Inc. and Apotex Corp.
Cause Of Action: 35 U.S.C. § 1
Eagle Pharmaceuticals, Inc. v. Slayback Pharma LLC et al
as 1:2021cv01256
Plaintiff:
Eagle Pharmaceuticals, Inc.
Defendant:
Slayback Pharma LLC, Apotex Inc. and Apotex Corp.
Cause Of Action: 35 U.S.C. § 271
Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.
